Toxicity and metabolism of methylnaphthalenes

Comparison with naphthalene and 1-nitronaphthalene

Ching Yu Lin, Åsa M. Wheelock, Dexter Morin, R. Michael Baldwin, Myong Gong Lee, Aysha Taff, Charles Plopper, Alan R Buckpitt, Arlean Rohde

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Naphthalene and close structural analogues have been shown to cause necrosis of bronchiolar epithelial cells in mice by both inhalation exposure and by systemic administration. Cancer bioassays of naphthalene in mice have demonstrated a slight increase in bronchiolar/alveolar adenomas in female mice, and in inflammation and metaplasia of the olfactory epithelium in the nasal cavity. Similar work in rats demonstrated a significant, and concentration-dependent increase in the incidence of respiratory epithelial adenomas and neuroblastomas in the nasal epithelium of both male and female rats. Although the studies on the acute toxicity of the methylnaphthalene derivatives are more limited, it appears that the species selective toxicity associated with naphthalene administration also is observed with methylnaphthalenes. Chronic administration of the methylnaphthalenes, however, failed to demonstrate the same oncogenic potential as that observed with naphthalene. The information available on the isopropylnaphthalene derivatives suggests that they are not cytotoxic. Like the methylnaphthalenes, 1-nitronaphthalene causes lesions in both Clara and ciliated cells. However, the species selective lung toxicity observed in the mouse with both naphthalene and the methylnaphthalenes is not seen with 1-nitronaphthalene. With 1-nitronaphthalene, the rat is far more susceptible to parenteral administration of the compound than mice. The wide-spread distribution of these compounds in the environment and the high potential for low level exposure to humans supports a need for further work on the mechanisms of toxicity in animal models with attention to whether these processes are applicable to humans. Although it is tempting to suppose that the toxicity and mechanisms of toxicity of the alkylnaphthalenes and nitronaphthalenes are similar to naphthalene, there is sufficient published literature to suggest that this may not be the case. Certainly the enzymes involved in the metabolic activation of each of these substrates are likely to differ. The available data showing extensive oxidation of the aromatic nucleus of naphthalene, nitronaphthalene and the methylnaphthalenes (with some oxidation of the methyl group) contrast with the isopropylnaphthalene derivatives, where the major metabolites involve side chain oxidation. Overall, these data support the view that ring epoxidation is a key step in the process involved in cytotoxicity. Whether the epoxide itself or a downstream metabolite mediates the toxic effects is still not clear even with naphthalene, the best studied of this group of compounds. Additional work is needed in several areas to further assess the potential human health consequences of exposure to these agents. These studies should involve the definition of the extent and severity of methylnaphthalene toxicity after single dose exposures with attention to both the nasal and respiratory epithelia. The cytochromes P450 responsible for the initial activation of these agents in rodents with subsequent complimentary studies in primate models should help determine whether key metabolic processes responsible for toxicity occur also in primates. Finally, the precise involvement of reactive metabolite formation and adduction of cellular proteins in toxicity will be important in not only assessing the potential for human toxicity, but also in developing an understanding of the genetic and environmental factors which could alter the toxicity of these agents.

Original languageEnglish (US)
Pages (from-to)16-27
Number of pages12
JournalToxicology
Volume260
Issue number1-3
DOIs
StatePublished - Jun 16 2009
Externally publishedYes

Fingerprint

Metabolism
Toxicity
Nasal Mucosa
Metabolites
Adenoma
Rats
Primates
Derivatives
Oxidation
Inhalation Exposure
Olfactory Mucosa
Respiratory Mucosa
naphthalene
1-nitronaphthalene
Nasal Cavity
Poisons
Epoxy Compounds
Chemical activation
Metaplasia
Neuroblastoma

Keywords

  • 1-Methylnaphthalene
  • 1-Nitronaphthalene
  • 2-Methylnaphthalene
  • Clara cells
  • Cytochrome P450
  • Dimethylnaphthalenes
  • Naphthalene
  • Nasal toxicity
  • Respiratory tract

ASJC Scopus subject areas

  • Toxicology

Cite this

Lin, C. Y., Wheelock, Å. M., Morin, D., Baldwin, R. M., Lee, M. G., Taff, A., ... Rohde, A. (2009). Toxicity and metabolism of methylnaphthalenes: Comparison with naphthalene and 1-nitronaphthalene. Toxicology, 260(1-3), 16-27. https://doi.org/10.1016/j.tox.2009.03.002

Toxicity and metabolism of methylnaphthalenes : Comparison with naphthalene and 1-nitronaphthalene. / Lin, Ching Yu; Wheelock, Åsa M.; Morin, Dexter; Baldwin, R. Michael; Lee, Myong Gong; Taff, Aysha; Plopper, Charles; Buckpitt, Alan R; Rohde, Arlean.

In: Toxicology, Vol. 260, No. 1-3, 16.06.2009, p. 16-27.

Research output: Contribution to journalArticle

Lin, CY, Wheelock, ÅM, Morin, D, Baldwin, RM, Lee, MG, Taff, A, Plopper, C, Buckpitt, AR & Rohde, A 2009, 'Toxicity and metabolism of methylnaphthalenes: Comparison with naphthalene and 1-nitronaphthalene', Toxicology, vol. 260, no. 1-3, pp. 16-27. https://doi.org/10.1016/j.tox.2009.03.002
Lin, Ching Yu ; Wheelock, Åsa M. ; Morin, Dexter ; Baldwin, R. Michael ; Lee, Myong Gong ; Taff, Aysha ; Plopper, Charles ; Buckpitt, Alan R ; Rohde, Arlean. / Toxicity and metabolism of methylnaphthalenes : Comparison with naphthalene and 1-nitronaphthalene. In: Toxicology. 2009 ; Vol. 260, No. 1-3. pp. 16-27.
@article{a88f1a01d5fe472994e6698ca86b0b90,
title = "Toxicity and metabolism of methylnaphthalenes: Comparison with naphthalene and 1-nitronaphthalene",
abstract = "Naphthalene and close structural analogues have been shown to cause necrosis of bronchiolar epithelial cells in mice by both inhalation exposure and by systemic administration. Cancer bioassays of naphthalene in mice have demonstrated a slight increase in bronchiolar/alveolar adenomas in female mice, and in inflammation and metaplasia of the olfactory epithelium in the nasal cavity. Similar work in rats demonstrated a significant, and concentration-dependent increase in the incidence of respiratory epithelial adenomas and neuroblastomas in the nasal epithelium of both male and female rats. Although the studies on the acute toxicity of the methylnaphthalene derivatives are more limited, it appears that the species selective toxicity associated with naphthalene administration also is observed with methylnaphthalenes. Chronic administration of the methylnaphthalenes, however, failed to demonstrate the same oncogenic potential as that observed with naphthalene. The information available on the isopropylnaphthalene derivatives suggests that they are not cytotoxic. Like the methylnaphthalenes, 1-nitronaphthalene causes lesions in both Clara and ciliated cells. However, the species selective lung toxicity observed in the mouse with both naphthalene and the methylnaphthalenes is not seen with 1-nitronaphthalene. With 1-nitronaphthalene, the rat is far more susceptible to parenteral administration of the compound than mice. The wide-spread distribution of these compounds in the environment and the high potential for low level exposure to humans supports a need for further work on the mechanisms of toxicity in animal models with attention to whether these processes are applicable to humans. Although it is tempting to suppose that the toxicity and mechanisms of toxicity of the alkylnaphthalenes and nitronaphthalenes are similar to naphthalene, there is sufficient published literature to suggest that this may not be the case. Certainly the enzymes involved in the metabolic activation of each of these substrates are likely to differ. The available data showing extensive oxidation of the aromatic nucleus of naphthalene, nitronaphthalene and the methylnaphthalenes (with some oxidation of the methyl group) contrast with the isopropylnaphthalene derivatives, where the major metabolites involve side chain oxidation. Overall, these data support the view that ring epoxidation is a key step in the process involved in cytotoxicity. Whether the epoxide itself or a downstream metabolite mediates the toxic effects is still not clear even with naphthalene, the best studied of this group of compounds. Additional work is needed in several areas to further assess the potential human health consequences of exposure to these agents. These studies should involve the definition of the extent and severity of methylnaphthalene toxicity after single dose exposures with attention to both the nasal and respiratory epithelia. The cytochromes P450 responsible for the initial activation of these agents in rodents with subsequent complimentary studies in primate models should help determine whether key metabolic processes responsible for toxicity occur also in primates. Finally, the precise involvement of reactive metabolite formation and adduction of cellular proteins in toxicity will be important in not only assessing the potential for human toxicity, but also in developing an understanding of the genetic and environmental factors which could alter the toxicity of these agents.",
keywords = "1-Methylnaphthalene, 1-Nitronaphthalene, 2-Methylnaphthalene, Clara cells, Cytochrome P450, Dimethylnaphthalenes, Naphthalene, Nasal toxicity, Respiratory tract",
author = "Lin, {Ching Yu} and Wheelock, {{\AA}sa M.} and Dexter Morin and Baldwin, {R. Michael} and Lee, {Myong Gong} and Aysha Taff and Charles Plopper and Buckpitt, {Alan R} and Arlean Rohde",
year = "2009",
month = "6",
day = "16",
doi = "10.1016/j.tox.2009.03.002",
language = "English (US)",
volume = "260",
pages = "16--27",
journal = "Toxicology",
issn = "0300-483X",
publisher = "Elsevier Ireland Ltd",
number = "1-3",

}

TY - JOUR

T1 - Toxicity and metabolism of methylnaphthalenes

T2 - Comparison with naphthalene and 1-nitronaphthalene

AU - Lin, Ching Yu

AU - Wheelock, Åsa M.

AU - Morin, Dexter

AU - Baldwin, R. Michael

AU - Lee, Myong Gong

AU - Taff, Aysha

AU - Plopper, Charles

AU - Buckpitt, Alan R

AU - Rohde, Arlean

PY - 2009/6/16

Y1 - 2009/6/16

N2 - Naphthalene and close structural analogues have been shown to cause necrosis of bronchiolar epithelial cells in mice by both inhalation exposure and by systemic administration. Cancer bioassays of naphthalene in mice have demonstrated a slight increase in bronchiolar/alveolar adenomas in female mice, and in inflammation and metaplasia of the olfactory epithelium in the nasal cavity. Similar work in rats demonstrated a significant, and concentration-dependent increase in the incidence of respiratory epithelial adenomas and neuroblastomas in the nasal epithelium of both male and female rats. Although the studies on the acute toxicity of the methylnaphthalene derivatives are more limited, it appears that the species selective toxicity associated with naphthalene administration also is observed with methylnaphthalenes. Chronic administration of the methylnaphthalenes, however, failed to demonstrate the same oncogenic potential as that observed with naphthalene. The information available on the isopropylnaphthalene derivatives suggests that they are not cytotoxic. Like the methylnaphthalenes, 1-nitronaphthalene causes lesions in both Clara and ciliated cells. However, the species selective lung toxicity observed in the mouse with both naphthalene and the methylnaphthalenes is not seen with 1-nitronaphthalene. With 1-nitronaphthalene, the rat is far more susceptible to parenteral administration of the compound than mice. The wide-spread distribution of these compounds in the environment and the high potential for low level exposure to humans supports a need for further work on the mechanisms of toxicity in animal models with attention to whether these processes are applicable to humans. Although it is tempting to suppose that the toxicity and mechanisms of toxicity of the alkylnaphthalenes and nitronaphthalenes are similar to naphthalene, there is sufficient published literature to suggest that this may not be the case. Certainly the enzymes involved in the metabolic activation of each of these substrates are likely to differ. The available data showing extensive oxidation of the aromatic nucleus of naphthalene, nitronaphthalene and the methylnaphthalenes (with some oxidation of the methyl group) contrast with the isopropylnaphthalene derivatives, where the major metabolites involve side chain oxidation. Overall, these data support the view that ring epoxidation is a key step in the process involved in cytotoxicity. Whether the epoxide itself or a downstream metabolite mediates the toxic effects is still not clear even with naphthalene, the best studied of this group of compounds. Additional work is needed in several areas to further assess the potential human health consequences of exposure to these agents. These studies should involve the definition of the extent and severity of methylnaphthalene toxicity after single dose exposures with attention to both the nasal and respiratory epithelia. The cytochromes P450 responsible for the initial activation of these agents in rodents with subsequent complimentary studies in primate models should help determine whether key metabolic processes responsible for toxicity occur also in primates. Finally, the precise involvement of reactive metabolite formation and adduction of cellular proteins in toxicity will be important in not only assessing the potential for human toxicity, but also in developing an understanding of the genetic and environmental factors which could alter the toxicity of these agents.

AB - Naphthalene and close structural analogues have been shown to cause necrosis of bronchiolar epithelial cells in mice by both inhalation exposure and by systemic administration. Cancer bioassays of naphthalene in mice have demonstrated a slight increase in bronchiolar/alveolar adenomas in female mice, and in inflammation and metaplasia of the olfactory epithelium in the nasal cavity. Similar work in rats demonstrated a significant, and concentration-dependent increase in the incidence of respiratory epithelial adenomas and neuroblastomas in the nasal epithelium of both male and female rats. Although the studies on the acute toxicity of the methylnaphthalene derivatives are more limited, it appears that the species selective toxicity associated with naphthalene administration also is observed with methylnaphthalenes. Chronic administration of the methylnaphthalenes, however, failed to demonstrate the same oncogenic potential as that observed with naphthalene. The information available on the isopropylnaphthalene derivatives suggests that they are not cytotoxic. Like the methylnaphthalenes, 1-nitronaphthalene causes lesions in both Clara and ciliated cells. However, the species selective lung toxicity observed in the mouse with both naphthalene and the methylnaphthalenes is not seen with 1-nitronaphthalene. With 1-nitronaphthalene, the rat is far more susceptible to parenteral administration of the compound than mice. The wide-spread distribution of these compounds in the environment and the high potential for low level exposure to humans supports a need for further work on the mechanisms of toxicity in animal models with attention to whether these processes are applicable to humans. Although it is tempting to suppose that the toxicity and mechanisms of toxicity of the alkylnaphthalenes and nitronaphthalenes are similar to naphthalene, there is sufficient published literature to suggest that this may not be the case. Certainly the enzymes involved in the metabolic activation of each of these substrates are likely to differ. The available data showing extensive oxidation of the aromatic nucleus of naphthalene, nitronaphthalene and the methylnaphthalenes (with some oxidation of the methyl group) contrast with the isopropylnaphthalene derivatives, where the major metabolites involve side chain oxidation. Overall, these data support the view that ring epoxidation is a key step in the process involved in cytotoxicity. Whether the epoxide itself or a downstream metabolite mediates the toxic effects is still not clear even with naphthalene, the best studied of this group of compounds. Additional work is needed in several areas to further assess the potential human health consequences of exposure to these agents. These studies should involve the definition of the extent and severity of methylnaphthalene toxicity after single dose exposures with attention to both the nasal and respiratory epithelia. The cytochromes P450 responsible for the initial activation of these agents in rodents with subsequent complimentary studies in primate models should help determine whether key metabolic processes responsible for toxicity occur also in primates. Finally, the precise involvement of reactive metabolite formation and adduction of cellular proteins in toxicity will be important in not only assessing the potential for human toxicity, but also in developing an understanding of the genetic and environmental factors which could alter the toxicity of these agents.

KW - 1-Methylnaphthalene

KW - 1-Nitronaphthalene

KW - 2-Methylnaphthalene

KW - Clara cells

KW - Cytochrome P450

KW - Dimethylnaphthalenes

KW - Naphthalene

KW - Nasal toxicity

KW - Respiratory tract

UR - http://www.scopus.com/inward/record.url?scp=67349149647&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349149647&partnerID=8YFLogxK

U2 - 10.1016/j.tox.2009.03.002

DO - 10.1016/j.tox.2009.03.002

M3 - Article

VL - 260

SP - 16

EP - 27

JO - Toxicology

JF - Toxicology

SN - 0300-483X

IS - 1-3

ER -